Enrollment on upfront high‐risk neuroblastoma trials by race, ethnicity, and poverty status: A report from the Children's Oncology Group

Documenti analoghi

• Outcomes of patients with intermediate‐risk neuroblastoma presenting with motor deficits relating to intraspinal tumor extension: A report from the Children's Oncology Group study ANBL0531
  di: Julie Voeller, et al.
  Pubblicazione: (2024)
• Late cognitive and adaptive outcomes of patients with neuroblastoma‐associated opsoclonus‐myoclonus‐ataxia‐syndrome: A report from the Children's Oncology Group
  di: Prerna Kumar, et al.
  Pubblicazione: (2024)
• Long‐Term Outcome of Young Infants With Suspected Neuroblastoma following Observation as Primary Therapy: A Report From the Children's Oncology Group
  di: Hetal Dholaria, et al.
  Pubblicazione: (2025)
• Percutaneous biopsy for the diagnosis, risk stratification, and molecular profiling of neuroblastoma: A single‐center retrospective study
  di: Sean Schoeman, et al.
  Pubblicazione: (2024)
• Yoga as a non‐pharmacologic therapy to reduce dinutuximab‐induced pain in patients with neuroblastoma
  di: Katie N. Parisio, et al.
  Pubblicazione: (2024)